Phages play a major role in shaping the composition, evolution and function of bacterial 15 communities. While bacteria and phages coexist in many natural environments, their 16 coexistence is often short-lived in the lab due to the evolution of phage resistance. However, 17 fitness costs associated with resistance and mutational loss of resistance alleles may limit the 18 durability of acquired resistances, potentially allowing phages to re-invade the population. 19
would remain fully resistant to reinfection by the same phage genotype. On the other hand, 69 there may be selection against CRISPR immunity due to costs in the form of autoimmunity 70 (Stern et al. 2010) , or if CRISPR is less effective under high phage exposure (Westra et al. 71 2015) . Additionally recent theory and data suggest that individual bacteria may lose their 72 CRISPR-resistance due to mutations in the cas genes or CRISPR arrays (Weissman et al. 73 2019) . 74
75
To test the durability of CRISPR-based immunity, we recurrently infected Pseudomonas 76 aeruginosa PA14 with phage DMS3vir (Cady et al. 2012 ), a mu-like phage (Budzik et al. 77 2004) . By sequentially re-introducing the phage at different time intervals we vary the 78 intensity of selection for resistance (surface mutation) and immunity (CRISPR) and track the 79 resulting ecological dynamics. By using a combination of experimental evolution and 80 genomic analyses we tease apart the population genetics that underpin this host-parasite 81 interaction. These results have implications for how genetic diversity can be both generated 82 and lost in bacterial populations and help explain the coexistence of bacteria and phages in 83 natural microbial communities. 84 85 86
Results 88
Populations lose the ability to drive phages extinct 89 CRISPR mediated immunity acts as an acquired, heritable genetic memory against phages 90 (Marraffini 2015) , however the timescales over which it is effective are unknown. Based on 91 our mechanistic understanding of CRISPR immunity, one would predict that population-level 92 immunity is long-lived. However, the few empirical studies that directly measure population 93 and evolutionary dynamics of CRISPR-phage interactions have either focussed on short-term 94 dynamics (Westra et al. 2015; van Houte et al. 2016) or examined CRISPR in isolation 95 (Paez-Espino et al. 2013; Common et al. 2019) , rather than the interplay between alternative 96 resistance strategies. Recent theory and data suggests that resistance alleles may be lost from 97 bacterial populations due to back mutations towards a sensitive phenotype when resistance is 98 costly, which can in turn allow for phage persistence (Weissman et al. 2018; Chaudhry et al. 99 2018; Gurney et al. 2019) . To test this, we exposed P. aeruginosa PA14, which carries a type 100 I-F CRISPR system, to phage DMS3vir, which carries a mutation in its repressor gene that 101 prevents lysogeny, as well as a partial protospacer match which promotes primed spacer 102 acquisition by P. aeruginosa PA14 (Westra et al. 2015) . We then measured whether 103 populations could repeatedly drive phage DMS3vir to extinction following an initial phage 104 exposure. Consistent with earlier findings, following the first infection treatment, phage titers 105 were found to initially increase due to the phage epidemic that takes place in the sensitive 106 bacterial population, followed by a rapid decline in phage titers and extinction at 4 days post 107 infection (dpi) (Fig. 1A) , due to the evolution of CRISPR-based immunity in the bacterial 108 population (van Houte et al. 2016 and Fig. 2 ). To test whether these now immunized bacteria 109 could survive subsequent infections they were reinfected with 10 7 pfu phage at 5 dpi. 110
Consistent with the bacterial population having evolved CRISPR-mediated phage resistance 111 in response to the earlier phage challenge the phage was rapidly driven to extinction (Fig. 112 1B) . Strikingly, when the same bacterial populations were re-infected 5 days later (at 10 dpi) 113 they had lost the ability to drive the phage extinct (Fig. 1B) , and phage was able to persist for 114 the remainder of the 30-day experiment in all replicates of the same treatment. Similarly, in 115 the treatment where the first re-infection took place at 10 dpi, the bacterial populations also 116 had lost the ability to drive phage extinct (Fig. 1C ). As expected, the treatment where phage 117 was added every day showed high phage titres throughout the experiment (Fig. 1D) , and in 118 the phage-free treatment no phage could be detected (data not shown). reinfection (n = 6). B) Reinfection every 5 days (n = 12). C) Reinfection every 10 days (n = 127 6). D) Daily reinfection. (n = 12). Phage titres were recorded every 2 days. Note this figure  128 includes imputed values for non-recorded days that combine the previous days titre with the 129 phages that were added. Limit of detection is 200 PFU per ml. 130 
Populations are invaded by surface resistance mutants and sensitive clones 132
To understand why phages can successfully re-infect populations that previously drove the 133 same phage extinct, we phenotypically characterised the composition of the host populations, 134
i.e. the proportion of sensitive bacteria as well as the proportion of bacteria that had acquired 135 at least one new spacer that conferred CRISPR-based immunity (CRISPR-immune herein) or 136 surface mutation based resistance (i.e. bacteria that evolved phage resistance through loss or 137 masking of the phage receptor, SM herein). At 4 dpi 0.66 ± 0.036 (mean proportion ± SE) of 138 bacteria in the populations from the single infected treatment evolved CRISPR-immunity, 139 0.25 ± 0.040 evolved SM resistance, and 0.083 ± 0.022 remained sensitive. At 30 dpi, these 140 fractions had changed to 0.0069 ± 0.0069 CRISPR immunity, 0.38 ± 0.073 SM, and 0.61 ± 141 0.73 sensitives. The invasion of sensitive bacteria in the absence of phage suggests that either 142 CRISPR immunity is associated with a constitutive fitness cost, or that there is back mutation 143 from CRISPR immunity to the sensitive, ancestral genotype (examined in detail later). 144
Next, to understand how the reinfection regimes impact the evolutionary dynamics of 145 the host population, we examined how the evolution of CRISPR immunity and surface 146 resistance varied across our treatments. At 4 dpi, we found an interaction between the 147 proportion of each phenotype and reinfection frequency (GLM, F1, 102 = 7.06, p < 0.0001), 148 with populations that were re-infected daily had slightly increased levels of SM compared to 149 those only infected once (F1,35 = 17.94, p < 0.001), which is consistent with previous results 150 that demonstrate a shift towards SM when phage exposure is high (Westra et al. 2015) . 151
Interestingly, for all treatments, we observed a significant reduction in CRISPR-immune 152 clones over time (quasibinomial GLM, F1,22 = 179.8, p < 0.0001), but no interaction between 153 treatment and time (quasibinomial GLM, F1,16 = 2.4, p = 0.16), suggesting the reinfection 154 regime was not driving the observed decline. However, while in the single infection treatment 155 the decline in CRISPR-immune clones was due to the invasion of sensitive bacteria, we 156 observed invasion of surface resistant bacteria in the reinfection treatments instead ( which was identical in all independent isolates and hence suggests these areas of the genome 172 contain sequences with microhomology that are prone to recombination. In addition, we 173 carried out deep sequencing of CRISPR array amplicons (CRISPR1 and CRISPR2) of all 174 experimental populations. This demonstrated an extremely high spacer diversity (133249 175 unique CRISPR arrays) that is sufficient to cover all 5643 possible target sequences on the 176 phage genome ( Fig.S1 ). We found a significant interaction between time and reinfection 177 frequency, with spacer diversity declining in all groups with the exception of populations that 178 were infected daily, which maintained spacer diversity for longer (GLM, F1,85 = 6.65, p < 179 0.001, with qualitatively similar results for Shannon's or Simpson's diversity indices). F7  F8  F9  S1  S2  S3  S4  S5  S6  T1  T2  T3  T4  T5 The data discussed above show that CRISPR immunity dominates early on, but over time 205 sensitive bacteria and SM clones invade. Since sensitive bacteria will act as a source for 206 phage, we hypothesised that their invasion may be responsible for the observed bacteria-207 phage coexistence following re-infections at 10 dpi. Consistent with this hypothesis, bacterial 208 populations from 2 dpi were able to rapidly reduce phage DMS3vir titres whereas the same 209 populations from 12 dpi caused phage amplification (GLM, F1,46 = 172.29, p < 0.0001, Fig.  210 S2). Moreover, we found a strong interaction effect between phage titres and the proportion 211 of each phenotype in our experimental populations (GLM, F1,627 = 50.93, p < 0.0001). 212
Specifically, we found a positive correlation between phage titre and the frequency of 213 sensitive clones in the population (GLM, F1,209 = 12.3, adjusted p-value < 0.001), as well as a 214 negative correlation between phage titre and the frequency of CRISPR-immune clones 215 (GLM, F1,209, F = 41.6, adjusted p-value < 0.001) (Fig 4. ). As expected, the proportion of 216 clones with SM resistance correlates less strongly with phage titre (as this phenotype neither 217 amplifies nor degrades phages). Taken together, these results are consistent with the idea that 218 CRISPR clones act as a 'sink' for phages whilst sensitive bacteria act as a 'source' for phages 219 and that the protective effect is lost as CRISPR-immune bacteria decline in frequency. Fig S3) . Invasion of sensitives in the absence of phage may be driven by selection, 237 if sensitive bacteria are fitter than clones with CRISPR immunity under those conditions. 238
However, the observed increase in the frequency of sensitives may also result from back-239 mutation from a CRISPR immune genotype to sensitive (for example mutations in cas genes 240 can inactivate the immune system (Jiang et al. 2013) or recombination between CRISPR 241 repeats can result in spacer loss (Lopez-Sanchez et al. 2012). To tease these processes apart, 242
we competed clones with different phenotypes isolated from these evolution experiments 243 against an ancestral reference strain in the absence of phages. We found that although the 244 clones did increase in fitness by day 12 (GLMM, main effect of time, c 2 = 31.07, df = 6, p < 245 0.001, Fig. 5 ), there was no interaction between phenotype and time (GLMM, c 2 = 3.11, df = 246 11, p = 0.21) and no effect of treatment (GLMM, c 2 = 1.83, df = 9, p = 0.61). We also found 247 a borderline significant effect of phenotype (GLMM, c 2 = 6.54, df = 6, p = 0.038), however 248 post-hoc testing showed that there were no significant differences among phenotypes within 249 each timepoint (Table S1 ). When considered alongside the observed ecological dynamics, the 250 most parsimonious explanation is that sensitive bacteria invade the populations through the 251 loss of CRISPR immunity i.e. back-mutation where spacers are lost. This is most clear in the 252 single infection treatment where phages are absent: no phenotype has greater fitness yet 253 sensitive bacteria still invade ( In contrast, the rapid invasion of SM clones observed in the evolution experiment, in the 263 presence of phage, is likely explained by the fact that CRISPR immunity is associated with 264 an inducible cost (i.e. a cost that increase during phage infections (Westra et al. 2015) . 265
Indeed, a similar invasion of SM has been previously observed when a reservoir of sensitive 266 bacteria was introduced because the force of infection is increased (Chabas et al. 2016) . 267
However, it has remained unclear what the mechanistic basis of this cost is. We envisaged 268 of the CRISPR-Cas immune system following infection or (iii) due to expression of phage-271 encoded genes in the period between infection (i.e. phage genome injection) and CRISPR-272 mediated clearance of the phage. To explore the first hypothesis, we first performed a 273 competition experiment between bacteria with CRISPR immunity that are unable to acquire 274 novel spacers (i.e. a cas1 deletion mutant) and a surface mutant. This competition was 275 performed across a gradient of titres of DMS3mvir (a mutant of DMS3vir that is targeted by 276 spacer1 in CRISPR array 2 of the PA14Dcas1 strain; hence both the surface mutant and 277 competing bacterial genotypes being insensitive to this phage). If the induced fitness cost of 278 CRISPR-Cas immunity was due to the acquisition of self-targeting spacers, we would expect 279 the cas1 deletion mutant to outcompete the WT strain. However, this was not observed, with 280 the cas1 deletion mutant showing lower relative fitness than the WT strain (GLM, F1,70 = 281 17.85, p < 0.001, Fig. S4 ). This suggests that the observed phage-induced fitness cost is not 282 due to autoimmunity. Similarly, deep sequencing of bacterial populations that evolved phage 283 resistance against DMS3vir showed that self-targeting with either zero (n = 17) or a single 284 mismatch (n = 18) to the host-genome spacers were very rare (0.16% of all unique spacers). 285 However, one spacer was found to target both the phage and host genome with 100% 286 sequence identity (hypothetical protein YP_950448.1 and DUF1804 family protein 287 respectively). While this spacer was present in two populations, it was only observed at the 288 first timepoint sampled (day 2), consistent with the idea that there is strong selection against a 289 self-targeting spacer. Our results therefore suggest that although self-targeting is likely to be 290 deleterious, it is insufficient to explain the initial invasion of SM clones. 291
To explore whether expression of either host or phage genes following phage 292 infection caused the phage-induced cost of CRISPR-based immunity, we performed RNAseq 293 at 35, 60 and 120 minutes post-infection of a CRISPR immune clone that carries 2 spacers 294 targeting DMS3vir (BIM2). BIM2 shows complete immunity to DMS3vir and no phage 295 particles are produced following infection (data not shown; also see Landsberger et al. 2018). 296
Differential expression analysis found no evidence that CRISPR-Cas expression is enhanced 297 following infection ( Fig. S5) . Of all CRISPR-Cas genes, only Cas1 showed a significant 298 difference, with slightly lower expression in infected BIM2 populations relative to controls 299 (FDR adjusted p-value = 0.017, log2 fold change = -0.375). Finally, to test whether we 300 could detect phage gene expression in the infected BIM2 populations we mapped reads to the 301 DMS3vir genome. This revealed significant levels of genome-wide phage gene expression in 302 the BIM2 populations, despite their CRISPR-based immunity. In total, phage expression in 303 the BIM2 populations was around 5-fold lower compared to infected WT populations (Fig.  304   S6 ). Amongst the expressed phage genes, we identified very high levels of anti-CRISPR 305 (acr) and associated repressor (aca) expression ( Fig. S6 ), which has previously been reported 306 to be amongst the most strongly expressed genes on the phage DMS3vir genome (Stanley et 307 al. 2019 ), and to a lesser degree, many other genes ( Fig S7) . This acr protein is specific for 308 type I-E CRISPR-Cas systems and does not impact the type I-F CRISPR-Cas system encoded 309 by PA14. Collectively, these data show that the phage is capable of expressing its genes prior 310 to CRISPR mediated cleavage. 311
To test whether expression of the acr or aca genes might be responsible for the 312 phage-induced fitness cost in CRISPR-immune bacteria, we next competed the BIM2 strain 313 and the surface mutant in the presence of either WT DMS3vir, an acr deletion mutant, and a 314 mutant carrying a deletion of the entire acr operon. This revealed a similar fitness cost 315 regardless of the phage genotype (GLM, effect of genotype on relative fitness of BIM vs SM, 316 F1,50 = 2.15, p = 0.12). However, given that many other phage genes are also expressed, albeit 317 at lower levels, the induced cost may well be due to expression of one or more other phage 318 genes. We hypothesized that expression of the protease I gene might be particularly costly, 319 since proteolytic activity could conceivably cause cytotoxicity in the cell. This essential gene 320 is located immediately downstream of the acr and aca genes, and was found to be expressed 321 both in this experiment as well as an independent RNAseq experiment using nanopore 322 sequencing (data not shown). Given that a protease I deletion mutant would not be viable, we 323 cloned and expressed the protease gene in WT P. aeruginosa to measure the cost of 324 expression of this gene for the host. This showed that protease I expression reduced cell 325 growth rates by approximately 13% relative to an empty vector control (GLM, F1, 46 = 28.72, 326 p < 0.001). Given that this is just one of the many genes expressed by the phage during 327 infection it seems likely that phage gene expression prior to clearance of the infection is a 328 source of the observed phage-induced cost of CRISPR-based immunity. However, we note 329 that there may be additional unknown factors that contribute to an inducible-cost. 330 331 332 333
Discussion 334
Here we demonstrate that bacteria are rapidly immunised following phage infection and the 335 population is driving the phage to extinction. However, the success of this immunisation is 336 transient and successive re-introduction of the phage leads to stable coexistence between 337 bacteria and phages. This is due to the invasion of bacteria with SM resistance as well as 338 sensitive bacteria, which is caused by both an inducible fitness cost of CRISPR-based 339 immunity and the loss of spacers. We attribute the inducible cost to the phage gene 340 expression we observe which likely occurs prior to clearance of the infection by the CRISPR 
Materials and Methods 377
Bacterial strains and phages 378
The previously described P. aeruginosa strains UCBPP-PA14 and the isogenic mutant 379 csy3::LacZ and phage DMS3vir have been previously described (Cady et al. 2012 ) and were 380 used throughout this study. 381
382

Evolution experiments 383
Evolution experiments were performed in 6 replicates by inoculating 6 ml M9 supplemented 384 with 0.2% glucose or LB with approximately 10 6 bacteria from fresh overnight cultures of the 385 WT strain and adding 10 7 pfu of DMS3vir, followed by incubation at 37 ºC while shaking at 386 180 rpm. Cultures were transferred daily 1:100 for 30 days. Reinfections with ancestral phage 387 (10 7 pfu) were performed as follows: a) bacterial cultures in the single infection treatment 388 were only infected at t=0 b) bacterial cultures in the 5 day re-infection treatment were 389 infected at t=0, 5, 10, 15, 20 and 25 dpi c) bacterial cultures in the 10 day re-infection 390 treatment were infected at t=0, 10 and 20 dpi d) bacterial cultures in the daily infection 391 treatment were infected at each daily transfer. 392
Phage extraction and titration 394
Every second transfer, samples were taken just before transferring of the cultures into fresh 395 medium. Phage was isolated from these samples using chloroform extractions. Next, phage 396 was titrated by spotting serial dilutions of phage in M9 salts on a lawn of P. aeruginosa strain 397 UCBPP-PA14 csy3::LacZ bacteria for quantification. 398 were aligned to produce a single sequence for each pair that would entirely span the amplicon 437 using PEAR (version 0.9.10; (Zhang et al. 2014) ). Additionally, sequences with uncalled 438 bases (Ns) were removed. To remove sequences originating from potential PCR primer 439 dimers or from any spurious amplification events, a size selection was applied to each 440 merged sequence set, respectively between 30-140bp for CRISPR1 and 70-500bp for 441 CRISPR2. Fragmented PhiX phage genome was added to the sequence library in order to 442 increase the sequence complexity. To remove any 'bleed through' of PhiX sequences, each 443 sample was compared with the complete PhiX sequence (GenBank gi9626372) using 444 BLASTN (Altschul et al. 1990 ). Sequences matching PhiX (E-value < 10-5) were filtered out 445 of the dataset. 446 447
Clustering and diversity metrics 448
For each dataset, any sequences passing the filters (from any sample) were merged into a 449 single file. This final sequence file, plus its own metadata file describing each sample, was 450 used for the analysis by using a custom pipeline based on QIIME 1.9.0 (Caporaso et al. 451 2010) . Clusters were defined using SWARM (Mahé et al. 2014 ), using the strictest (default) 452 parameters. This tool aggregates a sequence to a cluster if the sequence shows similarity with 453 any of the sequences already present in that cluster. Importantly, the similarity threshold is 454 not fixed but defined within the dataset. A minimum cluster size filter is applied to retain 455 clusters containing at least 2 sequences and potential chimeric-sequences due to PCR events 456 were discarded as well. To calculate the abundance of each cluster, sequences were then 457 aligned on the centroid sequence identified for each clusters, using a minimum similarity 458 threshold of 99% for the entire length of the sequence using the 'usearch_global' function in 459 VSEARCH. 460
461
The sequencing depth of all samples was explored using the 'Chao 1' (Chao, 1984) richness 462 index plotted as a rarefaction curve. Counts in the cluster abundance tables were repeatedly 463 sub-sampled (rarefied; 33 repetitions) at sampling depths of 1000, 12000, 22000, … 150000. 464
The average Chao1 value obtained by repeating the test 33 times is assigned as alpha-465 diversity at that specific number of reads for that sample implemented in Qiime. Because all 466 samples reached a clear asymptote, i.e. no samples were under-sampled with regards to 467 spacer diversity, rarefaction was not applied. An abundance table for each locus was used to 468 estimate the richness and evenness of the samples using the following estimators: total 469 observed sequence variants, Shannon, Simpson, Simpson evenness again conducted with 470 Qiime. 471
472
Whole-genome sequencing 473 474 Populations from T12 were plated and 12 resulting colonies were screened for their phage 475 resistance phenotype, as described above. An additional control of the ancestral PA14 476 laboratory stock was included. Each colony was then suspended in 100 ul H20 and streaked 477 across an LB agar plate. Cells were scraped from these plates and added to bead beating tubes 478 prior to shipping to the MicrobesNG service (Birmingham UK). Three beads were washed 479 with extraction buffer containing lysozyme and RNase A, incubated for 25 min at 37 C. 480
Proteinase K and RNaseA were added and incubated for 5 min at 65 C. Genomic DNA was 481 purified using an equal volume of SPRI beads and resuspended in EB buffer. DNA was 482 quantified in triplicates with the Quantit dsDNA HS assay in an Ependorff AF2200 plate 483 reader. Genomic DNA libraries were prepared using Nextera XT Library Prep Kit (Illumina,  484 San Diego, USA) following the manufacturer's protocol with the following modifications: phages were scored as "sensitive", those resistant to DMS3vir but sensitive to 505 DMS3vir+AcrF1 were scored as "CRISPR immune", and bacterial clones resistant to both 506 phages were scored as "surface mutants". CRISPR-Cas-mediated immunity was further 507 confirmed by PCR using primers CTAAGCCTTGTACGAAGTCTC and 508 CGCCGAAGGCCAGCGCGCCGGTG (for CRISPR 1) and 509 GCCGTCCAGAAGTCACCACCCG and TCAGCAAGTTACGAGACCTCG (for CRISPR 510 2). Surface modification was further confirmed on the basis of colony morphology (since 511 phage DMS3vir is pilus-specific, surface mutants have motility defects, resulting in a 512 modified colony morphology) and a lack of new CRISPR spacers. From these analyses 513 fractions of each phenotype (sensitive, CRISPR immune, surface mutant) were calculated for 514 each replicate experiment. 515 516
Statistical analyses 517
In most cases general linear models were used using the appropriate error structure and 518 model residuals were assessed for model fit. Significance was determined following stepwise 519 deletion of terms or through Tukey post-hoc testing with adjustment for multiple 520 comparisons. General linear mixed-effect models were used for the competition assays, with 521 population specified as a random effect, due to the non-independence of clones isolated from 522 the same populations. Mixed effect modelling was carried out using the 'lme4' package with 
